Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Arnst

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|February 7, 2018
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor EfficacySouvik Banerjee, Kinsie E Arnst, Yuxi Wang, et al.
Cancer Research|November 29, 2017
A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane ResistanceKinsie E Arnst, Yuxi Wang, Dong-Jin Hwang, et al.
Molecular Pharmacology|May 3, 2019
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor EfficacyKinsie E Arnst, Yuxi Wang, Zi-Ning Lei, et al.
Journal of Medicinal Chemistry|August 18, 2021
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization InhibitorSouvik Banerjee, Foyez Mahmud, Shanshan Deng, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|February 7, 2018
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor EfficacySouvik Banerjee, Kinsie E Arnst, Yuxi Wang, et al.
Cancer Research|November 29, 2017
A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane ResistanceKinsie E Arnst, Yuxi Wang, Dong-Jin Hwang, et al.
Molecular Pharmacology|May 3, 2019
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor EfficacyKinsie E Arnst, Yuxi Wang, Zi-Ning Lei, et al.
Journal of Medicinal Chemistry|August 18, 2021
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization InhibitorSouvik Banerjee, Foyez Mahmud, Shanshan Deng, et al.
Pageof 2